parietaria judaica herb, 97281-42-0

Articles:

PubMed:A battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy.

PubMed:Plant lipid transfer protein allergens: no cross-reactivity between those from foods and olive and Parietaria pollen.

PubMed:Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics.

PubMed:Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice.

PubMed:Detection of airborne Par j 1 and Par j 2 allergens in relation to Urticaceae pollen counts in different bioclimatic areas.

PubMed:Parietaria judaica flowering phenology, pollen production, viability and atmospheric circulation, and expansive ability in the urban environment: impacts of environmental factors.

PubMed:Proteomic analysis of Parietaria judaica pollen and allergen profiling by an immunoproteomic approach.

PubMed:Production of an egg yolk antibody against Parietaria judaica 2 allergen.

PubMed:Comparison of different diagnostic products for skin prick testing.

PubMed:Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses.

PubMed:Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.

PubMed:Aeroallergens in clinical practice of allergy in India- ARIA Asia Pacific Workshop report.

PubMed:Recombinant hypoallergens for immunotherapy of Parietaria judaica pollen allergy.

PubMed:Par j 1 and Par j 2, the two major allergens in Parietaria judaica, bind preferentially to monoacylated negative lipids.

PubMed:Effects of Parietaria judaica pollen extract on human microvascular endothelial cells.

PubMed:Allergenicity and cross-reactivity of Senecio pollen: identification of novel allergens using the immunoproteomics approach.

PubMed:Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.

PubMed:Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine.

PubMed:LAIS Allergoid.

PubMed:Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma.

PubMed:Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.

PubMed:CTLA-4 regulates allergen response by modulating GATA-3 protein level per cell.

PubMed:Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.

PubMed:Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I.

PubMed:Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.

PubMed:Parietaria pollen allergens.

PubMed:A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination.

PubMed:Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children.

PubMed:Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens.

PubMed:Allergenic proteins in Urtica dioica, a member of the Urticaceae allergenic family.

PubMed:Purification of a novel aminopeptidase from the pollen of Parietaria judaica that alters epithelial integrity and degrades neuropeptides.

PubMed:Detection and release of allergenic proteins in Parietaria judaica pollen grains.

PubMed:Electrophoresis of proteins and DNA on horizontal sodium dodecyl sulfate polyacrylamide gels.

PubMed:Correlation between Olea europaea and Parietaria judaica pollen counts and quantification of their major allergens Ole e 1 and Par j 1-Par j 2.

PubMed:Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma.

PubMed:[Allergy vaccination with only 4 injections per year].

PubMed:Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance.

PubMed:A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.

PubMed:Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study.

PubMed:Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.

PubMed:Aeroallergens sensitization in an allergic paediatric population of Cova da Beira, Portugal.

PubMed:Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjects.

PubMed:Urban versus rural environment--any differences in aeroallergens sensitization in an allergic population of Cova da Beira, Portugal?

PubMed:[Sensitization to Castanea sativa pollen and pollinosis in northern Extremadura (Spain)].

PubMed:Sublingual specific immunotherapy reduces PBMC proliferations.

PubMed:[Specific brief immunotherapy receives MMW Drug Prize 2004. Four pricks expel pollen allergy].

PubMed:[Every tenth person has hay fever complaints. To whom do you advise hyposensitization?].

PubMed:Skin tests with native, depigmented and glutaraldehyde polymerized allergen extracts.

PubMed:Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.

PubMed:Lipid transfer proteins in Parietaria judaica L. pollen grains: immunocytochemical localization and function.

PubMed:Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study.

PubMed:Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.

PubMed:A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.

PubMed:Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL) for the treatment of grass pollen allergy.

PubMed:PCR-based cloning and immunological characterization of Parietaria judaica pollen profilin.

PubMed:[Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen].

PubMed:Hypoallergenic variants of the Parietaria judaica major allergen Par j 1: in vitro and in vivo evaluation.

PubMed:[Rapid hyposensitization].

PubMed:The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.

PubMed:Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.

PubMed:Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts.

PubMed:Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate.

PubMed:Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.

PubMed:Characteristics of pollinosis caused by Betula in patients from Ourense (Galicia, Spain).

PubMed:Allergen biodistribution in humans.

PubMed:A multicenter evaluation of the CARLA system for the measurement of specific IgE antibodies vs. other different methods and skin prick tests.

PubMed:Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients.

PubMed:Occupational rhinitis and bronchial asthma due to artichoke (Cynara scolymus).

PubMed:Monitoring of seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic subjects with rhinitis and effect of specific immunotherapy.

PubMed:Identification of cross-reactive and genuine Parietaria judaica pollen allergens.

PubMed:Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions.

PubMed:Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.

PubMed:The allergens of Parietaria.

PubMed:Safety of inhalant allergen immunotherapy with mass units-standardized extracts.

PubMed:Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.

PubMed:[The influence of a three-year preseasonal specific immunotherapy on selected parameters of allergic inflammation in pollinosis patients].

PubMed:[Evaluation of effectiveness and safety of three year immunotherapy with mixed grass pollen allergens].

PubMed:[Efficacy of specific immunotherapy in children with seasonal allergic rhinitis and conjunctivitis, sensitized to grass pollen].

PubMed:Specific immune response to Parietaria judaica plant profilin: a low T cell proliferative response supports high IgE and skin prick test.

PubMed:The involvement of sensory neuropeptides in airway hyper-responsiveness in rabbits sensitized and challenged to Parietaria judaica.

PubMed:Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL).

PubMed:Detection and localisation of disulphide bonds in a synthetic peptide reproducing the sequence 1-30 of Par j 1.0101 by electrospray ionisation mass spectrometry.

PubMed:Parietaria pollinosis in an Atlantic area: clinical and palynological data.

PubMed:Hypoallergenic variants of the Parietaria judaica major allergen Par j 1: a member of the non-specific lipid transfer protein plant family.

PubMed:Specific immune response to Phleum pratense plant profilin in atopic patients and control subjects.

PubMed:Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers.

PubMed:The efficacy of oromucosal immunotherapy in respiratory allergy.

PubMed:The IgE-binding epitopes of rPar j 2, a major allergen of Parietaria judaica pollen, are heterogeneously recognized among allergic subjects.

PubMed:Local nasal immunotherapy and bronchial hyperreactivity in seasonal allergic rhinitis: an observational pilot study.

PubMed:A flavonoid sulfate antigen activates human alphabeta CD8+ Th2 lymphocytes in pollen allergy.

PubMed:[Factors associated with the development of atopy in young adults].

PubMed:Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.

PubMed:Characterization of a dodecapeptide containing a dominant epitope of Par j 1 and Par o 1, the major allergens of P. judaica and P. officinalis pollen.

PubMed:Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

PubMed:Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.

PubMed:Sensitization to pistachio is common in Parietaria allergy.

PubMed:Follow-up after systemic adverse reactions of immunotherapy.

PubMed:Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.

PubMed:Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy.

PubMed:Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours.

PubMed:Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.

PubMed:Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen.

PubMed:Immunotherapy and mast cell activation.

PubMed:An update on allergens. Parietaria pollen allergens.

PubMed:Determinations of Par j 1 by a competitive enzyme immunoassay using human specific IgE and IgG. Validation by skin prick testing.

PubMed:Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.

PubMed:Molecular characterization of a cross-reactive Juniperus oxycedrus pollen allergen, Jun o 2: a novel calcium-binding allergen.

PubMed:Prevalence and risk factors of latex sensitization in an unselected pediatric population.

PubMed:Late onset asthma clinical and immunological data: importance of allergy.

PubMed:Prevalence of atopy in students from Málaga, Spain.

PubMed:Identification of an immunodominant IgE epitope of the Parietaria judaica major allergen.

PubMed:Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells.

PubMed:Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings.

PubMed:Production and characterization of profilin monoclonal antibodies.

PubMed:Recombinant DNA technology in allergology: cloning and expression of plant profilins.

PubMed:Mercurialis annua: characterization of main allergens and cross-reactivity with other species.

PubMed:Isolation and characterization of two cDNA clones coding for isoforms of the Parietaria judaica major allergen Par j 1.0101.

PubMed:Allergen-specific conjunctival challenge in asthma. An additional diagnostic tool to define sensitization.

PubMed:Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.

PubMed:Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.

PubMed:cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen.

PubMed:Antiallergic activity of topical lodoxamide on in vivo and in vitro models.

PubMed:Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.

PubMed:Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro.

PubMed:Binding affinities of allergens from pollen, mites, and house dust for specific IgG subclass antibodies.

PubMed:[Sublingual immunotherapy].

PubMed:Comparison between outdoor and indoor airborne allergenic activity.

PubMed:Rush sublingual immunotherapy in Parietaria allergic patients.

PubMed:Immunocytochemical localization of allergenic proteins in Parietaria judaica L. (Urticaceae) pollen grains.

PubMed:Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy).

PubMed:Characterization of a dominant antigenic determinant of Par o I encoded by recombinant DNA.

PubMed:Parietaria judaica-specific T-cell clones from atopic patients: heterogeneity in restriction, V beta usage, and cytokine profile.

PubMed:Characterization of major allergens of Parietaria officinalis.

PubMed:[Effect of immunotherapy on selected immunologic indices in children with pollinosis].

PubMed:Parietaria pollinosis: clinical and epidemiological aspects.

PubMed:Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge.

PubMed:Quantitation of the major allergen of several Parietaria pollens by an anti-Par 1 monoclonal antibody-based ELISA. Analysis of crossreactivity among purified Par j 1, Par o 1 and Par m 1 allergens.

PubMed:IgE-binding trypsin inhibitors in plant pollen extracts.

PubMed:Use of monoclonal antibodies in the standardization of Parietaria judaica allergenic extracts.

PubMed:Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis.

PubMed:Comparative studies of allergenic extracts prepared from freshly collected, dried, or dried and defatted pollen.

PubMed:Allergen immunotherapy.

PubMed:Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study.

PubMed:Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge.

PubMed:Clinical effects of specific immunotheraphy in children with atopic dermatitis.

PubMed:[Course of hay fever during the pollen season with respect to the effect of specific immunotherapy. II. Cytologic changes and chemotactic activity in nasal lavage].

PubMed:[Characteristics of hay fever during pollen season with regard to the influence of specific immunotherapy. I. Clinical course and biochemical changes in nasal lavage].

PubMed:[Spontaneous histamine release by basophils and bronchial hyperreactivity in patients with hay fever].

PubMed:Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure.

PubMed:Evaluation of allergenic potency by REAST inhibition. A new tool for the standardization of allergenic extracts.

PubMed:Detection of Parietaria judaica airborne allergenic activity: comparison between immunochemical and morphological methods including clinical evaluation.

PubMed:Evaluation of the potency of allergenic extracts by inhibition of IgG-antibody binding.

PubMed:IgG subclass antibodies against Parietaria judaica in normal and allergic subjects.

PubMed:Modified par j I allergen from P judaica pollen and its rate of absorption in rats.

PubMed:cDNA cloning, expression and primary structure of Par jI, a major allergen of Parietaria judaica pollen.

PubMed:Comparison of skin-prick test assay and reverse enzyme immunoassay competition (REINA-C) for biological activity of allergens.

PubMed:Evaluation of the overall degree of sensitization to airborne allergens by a single serologic test: implications for epidemiologic studies of allergy.

PubMed:A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever.

PubMed:Isolation by mAb based affinity chromatography of two Par j I isoallergens. Comparison of their physicochemical, immunochemical and allergenic properties.

PubMed:[Comparative study between 10 and 20 mg of cetirizine in the symptomatic treatment of seasonal allergic rhinoconjunctivitis].

PubMed:Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test.

PubMed:Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge.

PubMed:T-cell and antibody response to Parietaria judaica allergenic fractions in atopic and nonatopic individuals.

PubMed:Protective effects of deflazacort on allergen-specific conjunctival challenge.

PubMed:Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.

PubMed:Determination of specific IgG antibodies with an immunofluorescence method (IF) before and after vaccination with Pollinex.

PubMed:Effect of specific immunotherapy on IgE immune complexes in seasonal allergic rhinitis.

PubMed:Asthma trough to Parietaria in pediatrics.

PubMed:Antigenic activity of nonpollen parts (leaves and stems) of allergenic plants (Parietaria judaica and Dactylis glomerata).

PubMed:[Level of specific IgE and IgG in blood serum of patients with hay fever after several cycles of desensitization with pollinex vaccine].

PubMed:Allergenic fragments in Parietaria judaica pollen extract.

PubMed:Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.

PubMed:Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).

PubMed:Studies on the relationship between structure and IgE-binding ability of Parietaria judaica allergen I.

PubMed:[Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].

PubMed:[Circulating immune complexes in patients treated with Pollinex vaccine].

PubMed:Late asthmatic reaction to perennial and seasonal allergens.

PubMed:Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis.

PubMed:HPLC purification of the main allergen of Parietaria judaica pollen.

PubMed:Isolation and in vitro translation of mRNA from inflorescences of Parietaria judaica.

PubMed:T cell responses to a Parietaria judaica pollen extract: comparison between Parietaria-sensitive patients, other atopics and healthy controls.

PubMed:Purification of Parj I, a major allergen from Parietaria, judaica pollen.

PubMed:Sensitivity to Parietaria pollen in the Southampton area as determined by skin-prick and RAST tests.

PubMed:Hypersensitivity to wheat flour in bakers.

PubMed:Micropreparative-scale enrichment of some allergenic components of Parietaria pollen extract.

PubMed:Analysis of allergenic components of a Parietaria judaica pollen extract by chromatographic methods for the evaluation of purification procedures.

PubMed:Parietaria judaica and dermo-respiratory allergy in Barcelona: a study of 250 cases.

PubMed:[Specific immunotherapy in the treatment of hay fever].

PubMed:Purification and molecular weight studies on the components of a Parietaria pollen extract.

PubMed:Purification of Par j I, the major allergen of Parietaria judaica pollen.

PubMed:Studies on the specificity of the IgA-binding lectin, jacalin.

PubMed:IgG and IgE antibody response following Pollinex-R immunotherapy.

PubMed:Purification of allergens by high-performance liquid chromatography. VI. Purification of the major allergen from Parietaria judaica pollen.

PubMed:[Blood basophil histamine and immunoglobulin levels in children with bronchial asthma treated with Pollinex].

PubMed:The effect of immunotherapy in hayfever patients on histamine binding capacity of blood serum proteins.

PubMed:Identification of IgE binding polypeptides cross-reactive with the Parietaria judaica main allergenic polypeptide.

PubMed:[Is the diagnostic differentiation between Parietaria officinalis and Parietaria judaica important for the specific immunotherapy?].

PubMed:Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population.

PubMed:Immunologic histamine release from isolated human basophils during specific immunotherapy.

PubMed:[The ideal time for the collection of Parietaria judaica L].

PubMed:[Diuretic and uricosuric activity of Parietaria judaica L].

PubMed:[Incorrect treatment of patients with allergic disorders].

PubMed:A comparison between pyridinic and non-pyridinic extraction of allergenic materials.

PubMed:Identification of Parietaria judaica pollen allergens.

PubMed:Human IgG antibody responses to grass pollen antigens: effects of immunotherapy and comparison of serum and secretory profiles.

PubMed:A four-step sandwich radioimmunoassay for direct selection of monoclonal antibodies to allergen molecules.

PubMed:A competitive solid-phase radioimmunoassay for quantitation of the major allergen of Parietaria pollen.

PubMed:[Circulating immune complexes in the serum of patients with hay fever during specific immunotherapy].

PubMed:Isolation of the major IgE-binding protein from Parietaria judaica pollen using monoclonal antibodies.

PubMed:[Effect of stimulation of beta-adrenergic and H2 receptors of polymorphonuclear granulocytes on the release of lysosomal enzymes in patients with hay fever before and after treatment with Pollinex].

PubMed:Cross-reactivity between Parietaria judaica and Parietaria officinalis.

PubMed:Distribution of allergen activity and identification of the main IgE-binding glycopeptide of Parietaria judaica pollen.

PubMed:The effect of short-term immunotherapy with Pollinex on anti-IgE and antigen-induced histamine release from sensitive human basophils.

PubMed:Immunochemical characterization of antigens of Parietaria judaica pollen. Identification of allergens by means of crossed radio immunoelectrophoresis.

PubMed:[Radioimmunologic tests in specific immunotherapy of atopic rhinitis].

PubMed:[Histamine level of basophils in children with pollinosis treated with pollinex].

PubMed:[Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex].

PubMed:Identification and characterization of Parietaria judaica allergens.

PubMed:Allergens of Parietaria judaica pollen--I. Purification and characterization of a hapten and a low molecular weight allergenic peptide.

PubMed:Modified ragweed extract.

PubMed:Immunotherapy with glutaraldehyde treated tyrosine adsorbed grass pollen in the treatment of allergic rhinitis.

PubMed:A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics.

parietaria judaica herb
pellitory herb

Supplier Sponsors

Articles:

parietaria judaica herb pellitory herb

Supplier Sponsors

Articles:

parietaria judaica herb
pellitory herb